Raffaella Casolino, Technical Officer in the Department of Noncommunicable Diseases, Rehabilitation, and Disability at WHO in Geneva, shared a post on LinkedIn:
“We are pleased to announce this new World Health Organization comprehensive analysis of > 89.000 Cancer Clinical Trials + Open access interactive data dashboard:
Academic publication in Nature Medicine (Nature Portfolio) here.
WHO summary publication for governments and developers here.
Open access interactive data dashboard here.
Together, these resources map the global distribution of cancer clinical trials and provide open access critical empirical evidence to inform policy and action.
What you can do with it:
• Benchmark: check and compare trial activity across countries/regions
• Prioritize: identify cancers, modalities, and geographies needing the greatest attention and investment.
• Plan and partner: design portfolios, target capacity, and build multi-country collaborations.
• Track progress: monitor shifts over time to see what’s working.
With thanks to ESMO – European Society for Medical Oncology for supporting this work.”
Title: The WHO global landscape of cancer clinical trials
Authors: Raffaella Casolino, Lambed Tatah, Sarah Charnaud, Marilina Santero, Andrè Ilbawi, Anna Laura Ross
More posts featuring Raffaella Casolino.